James N. Wilson, See Remarks at CORCEPT THERAPEUTICS INC (CORT), sold 25,117 shares at $113.94 ($2.9M) on 2026-09-01, disclosed to the SEC on 2026-09-03.
Scheduled sale ($2.9M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $113.94 | 11,730 | $1.3M | 46.5% |
| 2 | $114.71 | 10,989 | $1.3M | 43.9% |
| 3 | $115.61 | 2,281 | $264K | 9.2% |
| 4 | $113.38 | 117 | $13K | 0.5% |
| Total | $114.42 avg | 25,117 | $2.9M | 100% |
| Filing → |